Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced positive preliminary Phase 1 data from independent dose finding...
Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announces the launch of project SKY, the construction of...